Global Next Generation Sequencing (NGS) Market Size & Trends Report Segmented by Product and Service (Instruments, Consumables, Software), Technology (WGS, WES, Targeted Sequencing & Resequencing), End User & Regional Forecast to 2030
The global next generation sequencing market is set to witness a growth rate of ~15% in the next 5 years. Rising demand for precision medicine, technological advancements in sequencing platforms, falling costs of sequencing, growing use in clinical diagnostics, expanding applications beyond human genomics, increased government and private funding, are some of the key factors driving the next generation sequencing market. To learn more about the research report, download a sample report.
Report Overview
Next Generation Sequencing (NGS) is a DNA sequencing technology that has transformed the sequencing of whole genomes, exomes and targeted regions of the genome rapidly and with high accuracy. Unlike Sanger sequencing, which sequences large number of DNA fragments in parallel, but not simultaneously, NGS sequences about the same number of DNA fragments usually within the same time frame. It is extensively used in research, clinical diagnoses, personalized medicine, and agricultural industries for tasks such as mutation discovery, pathogen detection, gene expression analysis, and genotyping analysis. NGS has transformed genomics, allowing the implementation of massive projects that have driven progress in precision medicine, oncology, rare disease discovery, and infectious disease monitoring.
To learn more about this report, download the PDF brochure
Rising demand for precision medicine to drive market growth
Precision medicine is a method of customizing disease prevention and treatment, which utilize genomic information to assist in the delivery of the appropriate treatment to the appropriate patient at the appropriate time. Precision medicine has resulted in new treatments and FDA-approved drugs that are customized to unique characteristics of an individual. Next-generation sequencing technology has revolutionized the science of genomics and is quickly reshaping clinical diagnosis and precision medicine. This technology permits rapid and affordable examination of large-scale genomic data, making it possible to thoroughly examine the genetic scenery of disease. The speed, precision, and decreasing cost of NGS has facilitated the development of precision medicine, which entails planning treatment according to an individual's disease-causing molecular changes. Although NGS has been tried in various health care environments, its application is most advanced in cancer.
Integration of AI and ML into genomic data analysis – A key market trend
AI has significantly influenced the analysis of NGS data. AI algorithms increase efficiency and precision as they help in automating and enhancing various aspects of NGS data analysis. For instance, a key application of AI in NGS data analysis includes the alignment of sequences to a known reference genome, a crucial step in detecting genome variations and mutations. AI algorithms help in streamlining this process by identifying the most suitable matching sequences and compensating for data errors or variations. AI also helps in the development of novel NGS data analysis tools and methodologies. For instance, AI can be used to create algorithms capable of predicting the performance of various NGS assays or to discover innovative approaches to NGS data analysis. The ability of AI algorithms to speedily and accurately process large quantities of data renders them as indispensable tools in the field of NGS data analysis.
To learn more about this report, download the PDF brochure
Competitive Landscape Analysis
The global next generation sequencing market is marked by the presence of established and emerging market players such as Illumina, Inc.; Thermo Fisher Scientific, Inc.; Agilent Technologies, Inc.; F. Hoffmann-La Roche Ltd; DH Life Sciences, LLC; BGI Genomics Co., Ltd.; QIAGEN N.V.; Revvity; Eurofins Scientific; and PacBio; among others. Some of the key strategies adopted by market players include new product development, strategic partnerships and collaborations, and geographic expansion.
Report Scope
| Report Scope | Details |
| Base Year Considered | 2024 |
| Historical Data | 2023 – 2024 |
| Forecast Period | 2025 – 2030 |
| Growth Rate | 15% |
| Market Drivers |
|
| Attractive Opportunities |
|
| Segment Scope | Product and Service, Technology, Application, Workflow, End User |
| Regional Scope |
|
| Key Companies Mapped | Illumina, Inc.; Thermo Fisher Scientific, Inc.; Agilent Technologies, Inc.; F. Hoffmann-La Roche Ltd; DH Life Sciences, LLC; BGI Genomics Co., Ltd.; QIAGEN N.V.; Revvity; Eurofins Scientific; and PacBio; among others |
| Report Highlights | Market Size & Forecast, Growth Drivers & Restraints, Trends, Competitive Analysis |
Global Next Generation Sequencing Market Segmentation
This report by Medi-Tech Insights provides the size of the global next generation sequencing market at the regional- and country-level from 2023 to 2030. The report further segments the market based on product and service, technology, application, workflow, and end user.
Market Size & Forecast (2023-2030), By Product and Service, USD Million
- Instruments
- Consumables
- Services
- NGS Data Analysis Software and Platforms
Market Size & Forecast (2023-2030), By Technology, USD Million
- Whole Genome Sequencing (WGS)
- Whole Exome Sequencing
- Targeted Sequencing & Resequencing
- Others
Market Size & Forecast (2023-2030), By Application, USD Million
- Oncology
- Clinical Investigation
- Infectious Diseases
- Inherited Diseases
- Other Diseases
- Reproductive Health
- NIPT
- PGT
- New-born Genetic Screening
- Single Gene Analysis
- HLA Typing/Immune System Monitoring
- Metagenomics, Epidemiology & Drug Development
- Agri genomics & Forensics
- Consumer Genomics
- Others
Market Size & Forecast (2023-2030), By Workflow, USD Million
- Pre-Sequencing
- Sequencing
- NGS Data Analysis
Market Size & Forecast (2023-2030), By End User, USD Million
- Academic and Research Institutes
- Hospitals and Clinics
- Pharmaceutical and Biotechnology Companies
- Contract Research Organizations (CROs)
- Others
Market Size & Forecast (2023-2030), By Region, USD Million
- North America
- US
- Canada
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Rest of Asia Pacific
- Latin America
- Middle East & Africa
Key Strategic Questions Addressed
- What is the market size & forecast of the next generation sequencing market?
- What are historical, present, and forecasted market shares and growth rates of various segments and sub-segments of the next generation sequencing market?
- What are the key trends defining the market?
- What are the major factors impacting the market?
- What are the opportunities prevailing in the market?
- Which region has the highest share in the global market? Which region is expected to witness the highest growth rate in the next 5 years?
- Who are the major players operating in the market?
- What are the key strategies adopted by players?
- Introduction
- Introduction
- Market Scope
- Market Definition
- Segments Covered
- Regional Segmentation
- Research Timeframe
- Currency Considered
- Study Limitations
- Stakeholders
- List of Abbreviations
- Key Conferences and Events (2025-2026)
- Research Methodology
- Secondary Research
- Primary Research
- Market Estimation
- Bottom-Up Approach
- Top-Down Approach
- Market Forecasting
- Executive Summary
- Next Generation Sequencing (NGS) Market Snapshot (2025-2030)
- Segment Overview
- Regional Snapshot
- Competitive Insights
- Market Overview
- Market Dynamics
- Drivers
- Rising demand for precision medicine
- Technological advancements in sequencing platforms
- Falling costs of sequencing
- Growing use in clinical diagnostics
- Expanding applications beyond human genomics
- Increased government and private funding
- Restraints
- High initial capital investment
- Data storage and management challenges
- Shortage of skilled professionals
- Reimbursement and regulatory barriers
- Opportunities
- Expanding role in infectious disease surveillance
- Rise of direct-to-consumer (DTC) genomics
- Expansion of clinical applications
- Developing markets offer untapped potential
- Key Market Trends
- Integration of artificial intelligence and machine learning
- Emergence of cloud-based NGS analysis solutions
- Technological advancements in sequencing platforms
- Increasing investment and funding
- Unmet Market Needs
- Industry Speaks
- Drivers
- Market Dynamics
- Global Next Generation Sequencing (NGS) Market Size & Forecast (2023-2030), By Product & Service, USD Million
- Introduction
- Instruments
- Consumables
- Services
- NGS Data Analysis Software and Platforms
- Global Next Generation Sequencing (NGS) Market Size & Forecast (2023-2030), By Technology, USD Million
- Introduction
- Whole Genome Sequencing (WGS)
- Whole Exome Sequencing
- Targeted Sequencing & Resequencing
- Others
- Global Next Generation Sequencing (NGS) Market Size & Forecast (2023-2030), By Application, USD Million
- Introduction
- Oncology
- Clinical Investigation
- Infectious Diseases
- Inherited Diseases
- Other Diseases
- Reproductive Health
- NIPT
- PGT
- New-born Genetic Screening
- Single Gene Analysis
- HLA Typing/Immune System Monitoring
- Metagenomics, Epidemiology & Drug Development
- Agri genomics & Forensics
- Consumer Genomics
- Others
- Global Next Generation Sequencing (NGS) Market Size & Forecast (2023-2030), By Workflow, USD Million
- Introduction
- Pre-Sequencing
- Sequencing
- NGS Data Analysis
- Global Next Generation Sequencing (NGS) Market Size & Forecast (2023-2030), By End User, USD Million
- Introduction
- Academic and Research Institutes
- Hospitals and Clinics
- Pharmaceutical and Biotechnology Companies
- Contract Research Organizations (CROs)
- Others
- Global Next Generation Sequencing (NGS) Market Size & Forecast (2023-2030), By Region, USD Million
- Introduction
- North America Next Generation Sequencing (NGS) Market Size & Forecast (2023-2030), By Country, USD Million
- US
- Market Size & Forecast, By Product and Service (USD Million)
- Market Size & Forecast, By Technology (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By Workflow (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Canada
- Market Size & Forecast, By Product and Service (USD Million)
- Market Size & Forecast, By Technology (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By Workflow (USD Million)
- Market Size & Forecast, By End User (USD Million)
- US
- Europe Next Generation Sequencing (NGS) Market Size & Forecast (2023-2030), By Country, USD Million
- UK
- Market Size & Forecast, By Product and Service (USD Million)
- Market Size & Forecast, By Technology (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By Workflow (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Germany
- Market Size & Forecast, By Product and Service (USD Million)
- Market Size & Forecast, By Technology (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By Workflow (USD Million)
- Market Size & Forecast, By End User (USD Million)
- France
- Market Size & Forecast, By Product and Service (USD Million)
- Market Size & Forecast, By Technology (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By Workflow (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Italy
- Market Size & Forecast, By Product and Service (USD Million)
- Market Size & Forecast, By Technology (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By Workflow (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Spain
- Market Size & Forecast, By Product and Service (USD Million)
- Market Size & Forecast, By Technology (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By Workflow (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Rest of Europe
- Market Size & Forecast, By Product and Service (USD Million)
- Market Size & Forecast, By Technology (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By Workflow (USD Million)
- Market Size & Forecast, By End User (USD Million)
- UK
- Asia Pacific (APAC) Next Generation Sequencing (NGS) Market Size & Forecast (2023-2030), By Country, USD Million
- China
- Market Size & Forecast, By Product and Service (USD Million)
- Market Size & Forecast, By Technology (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By Workflow (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Japan
- Market Size & Forecast, By Product and Service (USD Million)
- Market Size & Forecast, By Technology (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By Workflow (USD Million)
- Market Size & Forecast, By End User (USD Million)
- India
- Market Size & Forecast, By Product and Service (USD Million)
- Market Size & Forecast, By Technology (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By Workflow (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Rest of Asia Pacific
- Market Size & Forecast, By Product and Service (USD Million)
- Market Size & Forecast, By Technology (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By Workflow (USD Million)
- Market Size & Forecast, By End User (USD Million)
- China
- Latin America (LATAM) Next Generation Sequencing (NGS) Market Size & Forecast (2023-2030), USD Million
- Market Size & Forecast, By Product and Service (USD Million)
- Market Size & Forecast, By Technology (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By Workflow (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Middle East & Africa (MEA) Next Generation Sequencing (NGS) Market Size & Forecast (2023-2030), USD Million
- Market Size & Forecast, By Product and Service (USD Million)
- Market Size & Forecast, By Technology (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By Workflow (USD Million)
- Market Size & Forecast, By End User (USD Million)
- Competitive Landscape
- Key Players and their Competitive Positioning
- Key Player Comparison
- Segment-wise Player Mapping
- Market Share Analysis (2024)
- Company Categorization Matrix
- Dominants/Leaders
- New Entrants
- Emerging Players
- Innovative Players
- Key Strategies Assessment, By Player (2022-2025)
- New Product and Service Launches
- Partnerships, Agreements, & Collaborations
- Mergers & Acquisitions
- Geographic Expansion
- Key Players and their Competitive Positioning
- Company Profiles*
(Business Overview, Financial Performance**, Products Offered, Recent Developments)
- Illumina, Inc.
- Thermo Fisher Scientific, Inc.
- Agilent Technologies, Inc.
- Hoffmann-La Roche Ltd
- DH Life Sciences, LLC
- BGI Genomics Co., Ltd.
- QIAGEN N.V.
- Revvity
- Eurofins Scientific
- PacBio
- Other Prominent Players
Note: *Indicative list
**For listed companies
The study has been compiled based on extensive primary and secondary research.
Secondary Research (Indicative List)
Primary Research
To validate research findings (market size & forecasts, market segmentation, market dynamics, competitive landscape, key industry trends, etc.), extensive primary interviews were conducted with both supply and demand-side stakeholders.
Supply Side Stakeholders:
- Senior Management Level: CEOs, Presidents, Vice-Presidents, Directors, Chief Technology Officers, Chief Commercial Officers
- Mid-Management Level: Product Managers, Sales Managers, Brand Managers, R&D Managers, Business Development Managers, Consultants
Demand Side Stakeholders:
- Stakeholders from Academic and Research Institutes; Hospitals and Clinics; Pharmaceutical and Biotechnology Companies; Contract Research Organizations (CROs), and Others
Breakdown of Primary Interviews
Market Size Estimation
Both ‘Top-Down & Bottom-Up Approaches’ were used to derive market size estimates and forecasts
Data Triangulation
Research findings derived through secondary sources & internal analysis was validated with Primary Interviews, Internal Knowledge Repository and Company’s Sales Data
